key: cord-0072336-y35u21np
authors: Castaldo, Luigi; Toriello, Marianna; Sessa, Raffaele; Izzo, Luana; Lombardi, Sonia; Narváez, Alfonso; Ritieni, Alberto; Grosso, Michela
title: Antioxidant and Anti-Inflammatory Activity of Coffee Brew Evaluated after Simulated Gastrointestinal Digestion
date: 2021-12-05
journal: Nutrients
DOI: 10.3390/nu13124368
sha: 8d2bbd9166cc4f4cbccd3c414b8dc4d8c150e4b6
doc_id: 72336
cord_uid: y35u21np

Coffee contains human health-related molecules, namely polyphenols that possess a wide range of pharmacological functions, and their intake is associated with reduced colon cancer risk. This study aimed to assess the changes in the anti-inflammatory and antioxidant activity of coffee after simulated gastrointestinal digestion. The evaluation of intracellular reactive oxygen species (ROS) levels in the HT-29 human colon cancer cell line and three in vitro spectrophotometric assays were performed to determine the antioxidant activity of the samples. Characterization of coffee composition was also assessed through a Q-Orbitrap high-resolution mass spectrometry analysis. The results highlighted that the levels of polyphenols in the digested coffee brews were higher than those of the non-digested ones. All assayed samples decreased the levels of intracellular ROS when compared to untreated cells, while digested coffee samples exhibited higher antioxidant capacity and total phenolic content than not-digested coffee samples. Digested coffee samples showed a higher reduction in interleukin-6 levels than the not-digested samples in lipopolysaccharide-stimulated HT-29 cells treated for 48 h and fewer cytotoxic effects in the MTT assay. Overall, our findings suggest that coffee may exert antioxidant and anti-inflammatory properties, and the digestion process may be able to release compounds with higher bioactivity.

Coffee is recognized as one of the most popular beverages globally due to its appreciated taste and aroma as well as to its stimulating properties [1] . Although previous studies have reported adverse effects related to coffee consumption [2] , mainly due to the presence of potential harmful contaminants such as acrylamide [3] , a growing amount of scientific data support the potential benefits of regular coffee intake for human health [4, 5] . Several epidemiological studies and meta-analyses confirmed an inverse relationship between regular coffee consumption and chronic diseases including cardiovascular disease, obesity, type 2 diabetes, Parkinson's disease, and a wide number of cancer types [6] [7] [8] [9] . Scientific studies indicate that coffee consumption may exert colorectal cancer protection [10] , which could be due to the capacity of coffee constituents to inhibit the nuclear factor kappa B (NF-κB) pathway in colon cancer cells [11] , suppress the activity of T-LAK cell-originated protein kinase (TOPK) [12] , and inhibit neoplastic cell transformation [13] and colon cancer metastasis by attenuating phosphorylation of extracellular signal-regulated kinase (ERKs) [14] . Moreover, coffee consumption was also associated with reduced insulin resistance [15] tests were 2,3,5-triphenyltetrazolio chloride (TPTZ), 2,2 -azino-bis-3-ethylbenzthiazoline-6-sulphonic acid (ABTS), sodium sulfate (NaSO 4 ), potassium persulphate (K 2 S 2 O 8 ), 6hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (commonly called Trolox), 1,1diphenyl-2-picrylhydrazyl (DPPH), potassium thiocyanate (KCNS), calcium chloride dihydrate (CaCl 2 2 H 2 O), monosodium phosphate (NaH 2 PO 4 ), anhydrous ferric chloride (FeCl 3 ), sodium hydroxide (NaOH), potassium chloride (KCl), sodium bicarbonate (NaHCO 3 ), and sodium acetate (C 2 H 3 NaO 3 ) were provided from Sigma-Aldrich (Saint Louis, MO, USA).

The enzymes and standards used to simulate in vitro GiD were pepsin (≥2500 U/mg solid) from porcine gastric mucosa, α-amylase (1000-3000 U/mg solid) from human saliva, bile salt, pancreatin, Pronase E (bacterial protease from Streptomyces griseus, ≥3.5 U/mg solid), pancreatin (8 × USP) from porcine pancreas, and Viscozyme L were acquired from Sigma-Aldrich (Saint Louis, MO, USA).

Solvents, namely formic acid (FA), methanol (MeOH), hydrochloric acid (HCl), and water (UHPLC-MS grade), were acquired from Merk (Darmstadt, Germany). Deionized water (<18 MX cm resistivity) was acquired from Millipore (Bedford, MA, USA).

Coffee bean (Coffea arabica L.) samples were acquired from a coffee shop located in Naples, Southern Italy. Coffee beans were roasted using a laboratory roaster (Probat-Sample roaster, Emmerich am Rhein, Germany) for 16 min at a temperature between 195 and 227 • C. The roasting degree reached a medium degree on the Agtrom disk of the SCA (tile 55). Then, roasted coffee beans were grounded to 0.4 mm particle size in a coffee grinder (DeLonghi, KG79, Treviso, Italy). The filtered coffee brews were prepared using an American machine (Aigostar Chocolate 30 HIK, Milan, Italy) working with a water temperature of 90 • C. Coffee brews were prepared from 50 g of coffee powder and a volume of 600 mL of hot deionized water as declared by the manufacturer. The coffee brews were collected, freeze-dried, and stored until the analysis.

Chromatographic analysis was carried out through an UHPLC (Dionex UltiMate 3000, Thermo Fisher Scientific, Waltham, MA, USA) prepared with a Quaternary UHPLC pump, a degassing system, and an autosampler device. Separation of polyphenols and caffeine was performed with a thermostated Kinetex (25 • C) column F5 (50 × 2.1 mm, 1.7 µm particle size, Phenomenex, Torrance, USA).

The eluent phase consisted of H 2 O (A) and MeOH (B) both prepared at 0.1% of FA. The separation gradient started with 100% A for 1 min, decreased to 20% A in 2 min, and decreased again reaching 0% A in 3 min. Then, the gradient rose up again reaching 100% A in 2 min and was held for 2 min for column re-equilibration. The injection volume was 5 µL, whereas 0.5 mL/min was the flow rate.

Mass spectrometry analysis was performed through a Q-Exactive Orbitrap mass spectrometer (Thermo Fischer Scientific, Waltham, MA, USA). An electrospray (ESI) source was simultaneously operated in fast positive/negative ion switching mode, setting two scan events (Full ion MS and All ion fragmentation: AIF) for all investigated compounds.

Full MS/AIF experiments were performed with the settings: automatic gain control (AGC) target, 1e6; mass resolution, 35,000 full width at half maximum (FWHM); microscans, 1; maximum injection time, 200 ms; and scan range, 80-1200 m/z for full MS analysis. AIF mode conditions were: maximum injection time 200 ms; mass resolving power to 17,500 FWHM, AGC target, 1e6; scan time, 0.10 s; scan range, 80-1200 m/z; isolation window, 5 m/z; and retention time to 30 s. The collision energies were varied in the range of 10-60 eV. In both scan events the instrument was set to auxiliary gas, 10; spray voltage, 3.5 kV; sheath gas 45; and capillary temperature to 275 • C.

Identification was performed considering exact mass measurements at a mass tolerance of 5 ppm. Data treatment was carried out using Quan/Qual Browser Xcalibur software 3.1.66.19 (Xcalibur, Thermo Fischer Scientific, Waltham, MA, USA). 

The in vitro digestion process was carried out according to the protocol proposed from INFOGEST network [40] . The simulated fluids (salivary: SSF; gastric: SGF; and intestinal: SIF) were prepared according to the proportion of salts described by Izzo et al. [41] (Table S1 , in the Supplementary Material).

In short, to simulate the oral phase, 5 mL of brewed coffee brew was mixed with 975 µL of water, 3.5 mL of SSF, 25 µL of 0.3 M CaCl 2 (H 2 O) 2 , and 0.5 mL of α-amylase enzyme (50 mg of 250 U/mg solid). Then, the solution was incubated in a shaker bath for 2 min at 37 • C. Afterward, 7.5 mL of SGF, 695 µL of water, 1.6 mL of pepsin solution (2000 U/mL), and 5 µL of 0.3 M CaCl 2 (H 2 O) 2 were added to the mixture to simulate gastric conditions. The pH of the solution was reduced to 3 with 1 M HCl, and after that, the sample was incubated for 2 h at 37 • C. Finally, to simulate the intestinal conditions, 2.5 mL of bile salt solution (65 mg/mL), 11 mL of SIF, 1.3 mL of water, 5 mL pancreatin solution (100 U/mL of trypsin activity), and 40 µL of 0.3 M CaCl 2 (H 2 O) 2 were added. The pH value of the mixture was increased to 7 using NaOH 1 M. After that, the solution was incubated for 120 min at 37 • C. Then, the samples were centrifuged at 5000× g at 37 • C for 10 min, and the remaining pellets were collected. In order to simulate the colonic stage, the pellets were treated according to a previously described procedure [42] . Briefly, 5 mL of Pronase E solution (1 mg/mL) was added. The mixture was incubated for 1 h at 37 • C. Finally, 5 mL of water and 150 µL of Viscozyme L were added to the mixture and incubated for 16 h at 37 • C. After that, the samples were centrifuged at 5000× g for 10 min. The supernatants were collected, freeze-dried, and stored until the analysis.

The antioxidant activity of the digested and not-digested coffee brew samples was assessed by using two different free radical scavenging activity methods, including ABTS and DPPH tests, and the ferric ion reducing antioxidant power assay, namely FRAP. Data obtained were expressed as mmol of Trolox equivalents (TE) per gram of sample dry weight (DW). Results were calculated from the calibration curve prepared in triplicate at 6 concentration levels (5-200 µM of Trolox).

The FRAP test was carried out according to a methodology previously described [43] . In short, the FRAP reagent was prepared by mixing 12.5 mL of acetate buffer (0.3 M, pH 3.6), 1.25 mL of FeCl 3 solution (20 mM), and 1.25 mL of TPTZ solution (10 mM). Then, 150 µL of sample was added to 2.85 mL of FRAP reagent. After 4 min, the values of absorbance at 593 nm were immediately recorded.

The ABTS test was carried out based on the procedure described by Dini et al. [44] . In short, forty-four microliters of K 2 S 2 O 8 (2.5 mM) was added to aqueous ABTS (2.5 mL; 7 mM). After 16 h at room temperature, the solution was diluted with EtOH to reach an absorbance value of 0.70 (±0.02) at 734 nm. Then, 100 µL of sample was added to 1000 µL of ABTS radical working solution. After 3 min, the values of absorbance were immediately recorded.

The DPPH test was performed using the procedure suggested by Dini et al. [45] . Briefly, 4 mg of DPPH was diluted with MeOH until the absorbance value reached 0.9 (±0.02) at 517 nm. Afterward, 1 mL of DPPH radical working solution was added to 0.20 mL of sample. After 10 min, the values of absorbance were immediately recorded. 

The Folin-Ciocalteu method was performed to evaluate the total phenolic content (TPC) value in accordance with the procedure previously described [46, 47] . In brief, 0.125 mL of Folin-Ciocalteu reagent and 0.50 mL of deionized H 2 O were mixed with 0.125 mL of sample. After 6 min of incubation at room temperature, 1 mL of H 2 O and 1.25 mL Na 2 CO 3 solution (7.5%) were added to the solution. Finally, after 90 min of incubation, the values of absorbance at 760 nm were immediately recorded. Results were calculated from the calibration curves prepared in triplicate at 6 concentration levels (0.25-0.01 mg/mL of gallic acid).

The HT-29 human colon carcinoma cell line was obtained from ATCC (American Type Culture Collection, Manassas, VA, USA). Cells were kept in Dulbecco's Modified Eagle's Medium, high glucose, in the presence of 10% fetal bovine serum, 4 mM glutamine, streptomycin (10 mg/mL), and penicillin (10 U/mL) as previously reported [48] . The cell culture was maintained at 37 • C and humidified atmosphere (5% CO 2 ). Moreover, in order to maintain growth in the log phase, cells were subcultured by trypsinization (all reagents from Sigma-Aldrich, Saint Louis, MO, USA). Cells have been routinely checked for mycoplasma contamination with the PCR Mycoplasma Test Kit (AppliChem A3744, Darmstadt, Germany). Only cells negative for mycoplasma contamination were used.

Individual stock solution of assayed samples (digested and not-digested coffee brews) at 2 mg/mL were prepared in cell culture media. Therefore, in order to set the optimal experimental conditions to evaluate intracellular ROS levels and to perform cell viability assays and Western blot analysis, HT-29 cells were initially treated with different concentrations of the assayed samples (0.250 to 2 mg/mL) as previously reported [11] for 24, 48, and 72 h.

Cell viability was evaluated through spectrophotometric assay using the thiazolyl blue tetrazolium bromide (MTT) test [49, 50] . Briefly, 24 h before treatment, cells were plated into 96-well plates (100 µL cell suspension per well) at a density of 5.5 × 10 5 cells/mL. Then, cells were treated with the investigated samples. After 24, 48, and 72 h of treatment, 10 µL of the MTT labeling reagent provided by the Cell Proliferation Kit I (Roche, Mannhein, Germany) was added to each well. After 4 h, 100 µL of detergent solubilization buffer 1× (10% SDS in 0.01M HCl) was added to dissolve the insoluble purple formazan products into a colored solution according to the procedure recommended by the manufacturer. Measurement of the soluble formazan product in each well was carried out by photometric reading at 570/690 nm on a Synergy H1 Hybrid Multi-Mode Microplate Reader (BioTek, Winooski, VT, USA).

Intracellular ROS level production was estimated using the fluorescent dye 2 7dichlorodihydrofluorescein diacetate (H 2 DCF-DA) [51] . Cells were plated in 96-well black plates (100 µL cell suspension per well) at a density of 5 × 10 5 cells/mL. After 48 h treatment with different concentrations of the assayed samples (0.250 and 0.500 mg/mL), the cells were washed twice with Dulbecco's Phosphate Buffered Saline (DPBS). In order to test ROS levels under challenging conditions, after 24 h treatment with 0.250 mg/mL of assayed samples, cells were exposed to 10 ng/mL LPS for an additional 24 h to induce ROS production [52] [53] [54] . All cell samples were incubated and labelled with 10 µM of H 2 DCF-DA diluted in Hank's Balanced Salt Solution (HBSS) at 37 • C for 20 min in the dark. Then, the dye was removed, and the cells were washed twice with PBS. Cells treated with 100 µM hydrogen peroxide (H 2 O 2 ) were used as positive control. Therefore, 

HT-29 cells were plated into 24-well plates at a density of 1.4 × 10 5 cells/mL. Cells were treated with the assayed samples at the concentrations of 0.250 and 0.500 mg/mL. After 24 h, cells were exposed further for 24 h to lipopolysaccharide (LPS) to induce inflammation (10 ng/mL). For protein extraction, cells were collected and washed twice with 4 mL of PBS by centrifugation at 1000 rpm for 10 min at 4 • C. The pellets were resuspended with 50 µL of RIPA Buffer (Thermo Fisher Scientific, Waltham, MA, USA), 0.5 µL of the protein inhibitor cocktail mixture (Sigma-Aldrich), and incubated for 30 min on ice. Then, the whole cell lysates were collected [55] [56] [57] . Protein concentration was measured by spectrophotometric analysis, according to the Bradford method [58] with the Bio-Rad protein analysis reagent (Bio-Rad Laboratories, Hercules, CA, USA). Western blot analysis was performed on 20 µg of total protein extracts. Cell extracts were separated using 4-15% Mini-Protean TGX Stain-Free Precast Gels reagent (Bio-Rad Laboratories) and transferred to membranes using Trans-Blot Turbo Transfer System (Bio-Rad Laboratories). Antibodies against actin (1:1000 dilution/#SC-1616; Santa Cruz Biotechnology, Santa Cruz, CA, USA), IL-6 (1:1000 dilution/#ab9324; Abcam, Cambridge, UK), IL-10 (1:1000 dilution/#sc-1783; Santa Cruz Biotechnology), and NF-kB p65 subunit (1:2000 dilution/#ab1604a; Millipore) were diluted in TBT-Tween 20 (TBT-T) buffer containing 5% of milk and applied to membranes, followed by overnight incubation at 4 • C. The next day, filters were washed three times with TBT-T for 5 min and incubated for 45 min with respective secondary antibodies conjugated to peroxidase. The antigen-antibody complexes were then detected using Clarity Western ECL Substrate (Bio-Rad Laboratories). Quantitative densitometry of bands was carried out by analyzing ChemiDoc system (Bio-Rad Laboratories), and the quantification of the signal was performed by ImageJ as previously reported [59, 60] .

Tukey's test, at the level of significance p-value ≤ 0.05, was used to evaluate differences in antioxidant activity and TPC content between average values of the assayed samples. Statistical differences between untreated control and treated cells were calculated using the two-way analysis of variance (ANOVA) or one-way ANOVA test followed by Dunnett's multiple comparisons test and/or multiple Student's t-tests, where appropriate. The level of significance was set at p-value ≤ 0.05, p-value ≤ 0.01 to be significant (* and **, respectively), and at p-value ≤ 0.001 to be highly significant (***). All analyses were performed in triplicate. Data treatment was performed using Stata 12 software (StataCorp LP, College Station, TX, USA).

UHPLC-Q-Orbitrap HRMS analysis was conducted to identify active molecules (n = 16), including caffeine, CGAs, and hydroxycinnamic acids, in the digested and notdigested samples. Optimal separation of the studied compounds in the assayed samples was achieved by the UHPLC system in a total run time of 13 min. However, the 5-and 4-feruloylquinic acids (FQAs) isomers were quantified as a sum, due to the suboptimal separation. The identification of active compounds was assessed in both Full ion MS and AIF modes. All experiments were conducted in negative ESI − mode, except for caffeine which showed improved fragmentation patterns in positive ESI + mode. Mass parameters including chemical formula, ion assignment, measured and theoretical mass (m/z), retention time (RT), and accuracy are shown in Table 1 CQA (m/z 353.08780) was performed by comparing the RT of the peaks with those of the standards and by comparison of fragmentation pattern obtained with data previously reported in the literature. 

Brewed coffee samples (digested and not-digested) were investigated using a UHPLC-Q-Orbitrap HRMS method. The quantitative analysis of the target compounds was carried out using calibration curves, and regression coefficients >0.990 were obtained for all analytes. Some important CGAs (n = 11), phenolic acids (n = 4), and caffeine were found in both digested and not-digested samples.

Total CGAs were quantified at concentrations ranging from 68.92 (not-digested samples) up to 81.50 mg/g (digested samples), as shown in Table 2 . In the here investigated samples, CQAs were found as the most detected compounds ranging from 43.31% (notdigested samples) to 46.45% (digested samples) of total CGAs. The CQAs were revealed in a concentration range between 29.85 and 37.86 mg/g. Notably, 5-CQA showed to be the more relevant CGA, being quantified in digested and not-digested samples at a mean value of 25.97 and 21.40 mg/g, respectively. Regarding the FQAs isomers, 3-and 4-FQA represented from 30.48 to 30.64% of total CGAs detected in the investigated samples, in a concentration range between 21.11 and 24.84 mg/g. As far as p-CoQAs are concerned, 5-pCoQA was the most abundant compound detected in both digested and not-digested samples at a mean value of 7.53 and 7.19 mg/g, respectively. Moreover, diCQAs mainly represented by 3,4-and 3,5-diCQA were detected at a concentration level of 2.61 and 2.23 mg/g in digested and not-digested samples, respectively. Concerning 3,4-FCQA and 4,5-CFQA isomers, they were found as the less relevant compounds being measured at concentrations ranging from 0.83 up to 1.41 mg/g. Table 2 . CGA (n = 11), phenolic acids (n = 4), and caffeine content in the assayed samples.

Not On the other hand, some important phenolic acids were quantified in the here-assayed samples. Digested samples showed higher total phenolic content (9.57 mg/g) when compared to not-digested samples (5.29 mg/g). Moreover, ferulic acid was found at a concentration level significantly higher than the other assayed phenolic acids, ranging from 2.71 (not-digested samples) up to 4.12 mg/g (digested samples). Apart from those, caffeine was assessed in the herein investigated samples. Not-digested samples showed higher caffeine content (19.96 mg/g) than the digested samples (17.68 mg/g), as shown in Table 2 .

The antioxidant activity of the digested and not-digested samples was measured and compared using three different tests (FRAP, DPPH, and ABTS). Data were displayed as millimoles of Trolox per 100 g of coffee brew dried matter (mean value and ±SD). The results are reported in Table 3 . In all assayed methods, the digested coffee brews showed significantly higher antioxidant capacity (p-value ≤ 0.05) than the not-digested coffee brews. Furthermore, the results revealed that the digested samples showed a two-fold increase in antioxidant activity in both DPPH and ABTS tests (51.4 vs. 22.8 and 89.2 vs. 44.6 mmol Trolox/100 g DW, respectively). As shown in Table 3 , the digested samples also showed a significantly higher TPC value (p-value ≤ 0.05) compared to not-digested coffee brew samples. In addition, the blank control resulting from the in vitro digestion experiments was tested, and the results are presented in Table S2 in the Supplementary Material. Comparing the FRAP, DPPH, and ABTS data against TPC values measured through the Folin-Ciocalteu test, strong positive correlations were observed (R 2 = 0.892, 0.984, and 0.892 for TPC vs. FRAP, vs. DPPH, and vs. ABTS, respectively). Differences between groups were statistically analyzed with Tukey's test; * p-value ≤ 0.05 was considered significant.

MTT assay was performed to evaluate the potential cytotoxicity exerted by notdigested and digested coffee extracts in HT-29 cells at different concentrations according to literature data [11] . As shown in Figure 1 , at concentrations ranging from 0.250 mg/mL to 0.750 mg/mL, both extracts showed similar low effects on cell viability, although it has to be noted that, at the lowest concentration used in this study (0.250 mg/mL), an increase in cell viability was observed in both cases. Conversely, at higher concentrations (1-2 mg/mL) cell viability was significantly reduced for both extracts as compared to untreated control. In this context, it is interesting to note that not-digested coffee samples showed dramatic reduction in cell viability after treatment with 2 mg/mL for 24 h (14%), 48 h (10%), and 72 h (3%). In contrast, exposure to digested samples at the same concentration resulted in a less marked reduction in cell viability, with 77% of viable cells detected at 24 h, 65% at 48 h, and 33% at 72 h ( Figure 1A-C) , thus suggesting that digested coffee exhibits less cytotoxic effects on HT-29 cells than not-digested coffee samples. To exclude effects mediated by the digestion fluid, the blank control resulting from in vitro digestion was analyzed by MTT assay and compared with untreated cells. Results ( Figure 1D ) indicated no significant differences between the blank control and untreated cells at 24 h, 48 h, and 72 h of treatment.

Changes in intracellular ROS levels in HT-29 cells were evaluated using the H 2 DCF-DA assay after 24 h, 48 h, and 72 h exposure to non-toxic doses (0.250 and 0.500 mg/mL) of non-digested and digested coffee samples. Cells treated with 100 µM H 2 O 2 were used as positive control. The data summarized in Figure 2 show that treatment with not-digested or digested coffee samples decreased the levels of intracellular ROS levels as compared to untreated cells. Even in this case, different trends of antioxidant activity were detected in not-digested and digested coffee samples, with digested coffee samples showing a more pronounced antioxidant capacity, more evident at the longer exposure times (48 h and 72 h) ( Figure 2B,C) . In addition, to verify the real effects mediated by the digested coffee and to exclude effects mediated by the digestion fluid, a blank control resulting from in vitro digestion was included in the H 2 DCF-DA assay showing no significant differences with untreated cells at each exposure time. , as compared to untreated cells. No significant differences were observed between blank control and untreated cells. ns: not statistically significant. Mean ± SD of three independent experiments were plotted on the graph. Differences were considered significant when p-value ≤ 0.05 and p-value ≤ 0.01 and highly significant when p-value ≤ 0.001. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001 versus untreated control (calculated as fold-change relative to untreated cells, arbitrarily set at 100%); # p ≤ 0.05, ## p ≤ 0.01, and ### p ≤ 0.001 not-digested coffee versus digested coffee.

Changes in intracellular ROS levels in HT-29 cells were evaluated using the H2DCF-DA assay after 24 h, 48 h, and 72 h exposure to non-toxic doses (0.250 and 0.500 mg/mL) of non-digested and digested coffee samples. Cells treated with 100 µ M H2O2 were used , as compared to untreated cells. No significant differences were observed between blank control and untreated cells. ns: not statistically significant. Mean ± SD of three independent experiments were plotted on the graph. Differences were considered significant when p-value ≤ 0.05 and p-value ≤ 0.01 and highly significant when p-value ≤ 0.001. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001 versus untreated control (calculated as fold-change relative to untreated cells, arbitrarily set at 100%); ### p ≤ 0.001 not-digested coffee versus digested coffee.

detected in not-digested and digested coffee samples, with digested coffee samples showing a more pronounced antioxidant capacity, more evident at the longer exposure times (48 h and 72 h) ( Figure 2B,C) . In addition, to verify the real effects mediated by the digested coffee and to exclude effects mediated by the digestion fluid, a blank control resulting from in vitro digestion was included in the H2DCF-DA assay showing no significant differences with untreated cells at each exposure time. ing from in vitro digestion related to untreated cells. Cells treated with 100 µ M H2O2 were used as positive control. Mean ± SD of three independent experiments were plotted on the graph. Differences were considered significant when p-value ≤ 0.05 and p-value ≤ 0.01 and highly significant when p-value ≤ 0.001. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001 versus untreated control (calculated as fold-change relative to untreated cells, arbitrarily set at 100%); # p ≤ 0.05, ## p ≤ 0.01, and ### p ≤ 0.001 not-digested coffee versus digested coffee. No significant differences were observed between blank control and untreated cells at 24 h, 48 h, and 72 h. ns: not statistically significant.

Western blotting analysis was performed to determine the antioxidant effects of the assayed samples in modulating the expression of the pro-inflammatory protein IL-6 and u n t r e a t e d b l a n k 0 . Mean ± SD of three independent experiments were plotted on the graph. Differences were considered significant when p-value ≤ 0.05 and p-value ≤ 0.01 and highly significant when p-value ≤ 0.001. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001 versus untreated control (calculated as fold-change relative to untreated cells, arbitrarily set at 100%); ## p ≤ 0.01 not-digested coffee versus digested coffee. No significant differences were observed between blank control and untreated cells at 24 h, 48 h, and 72 h. ns: not statistically significant.

Western blotting analysis was performed to determine the antioxidant effects of the assayed samples in modulating the expression of the pro-inflammatory protein IL-6 and NF-kB p65 subunit and the expression of the anti-inflammatory protein IL-10. Data obtained from HT-29 cells treated for 24 h with digested and not-digested coffee and then co-exposed to LPS for additional 24 h as pro-inflammatory action are shown in Figure 3 . Notably, the results highlighted that the digested coffee samples showed lower expression levels of IL-6 and NF-kB p65 subunit levels than the not-digested samples (1.35 vs. 0.90 arbitrary units and 1.08 vs. 0.90 arbitrary units, respectively), indicating that the digestion process releases molecular compounds with more effective anti-inflammatory activity than the native coffee samples ( Figure 3A,B,D,E) . Furthermore, to underline the anti-inflammatory effect of the assayed digested coffee sample, expression levels of the anti-inflammatory cytokine IL-10 were examined, resulting to be more enhanced in response to the treatment with digested coffee compared to not-digested coffee samples ( Figure 3A,C) . To better investigate the antioxidant capacity of not-digested and digested coffee, we also analyzed intracellular ROS levels using the H 2 DCF-DA assay after 48 h under challenging conditions after LPS treatment. In fact, according to scientific evidence, LPS treatment promotes intestinal inflammation by inducing intracellular ROS production and oxidative injury in HT-29 cells [52] [53] [54] . Based on these observations, LPS-treated cells, similarly to H 2 O 2 , showed 30% increased ROS levels compared with the untreated control, thus representing a challenging condition for oxidative stress. After stimulation with LPS, treatments with 0.25 mg/mL of not-digested or digested coffee significantly reduced the levels of ROS in HT-29 cells relative to LPS-stimulated cells by 15% and 30%, respectively. These results confirmed the pro-oxidant status induced by LPS stimulus and suggest that the more protective effects observed for digested coffee treatment are mediated, at least in part, by antioxidant mechanisms of ROS scavenging (Figure 4 ). Band intensities were quantified and normalized to actin used as control. All data were analyzed for statistical significance by two-way ANOVA, followed by Dunnett's multiple comparison test where appropriate. Differences were considered significant when p-value ≤ 0.05 and p-value ≤ 0.01 and highly significant when p-value ≤ 0.001. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001 versus untreated control (calculated as fold-change relative to untreated cells, arbitrarily set at 1); # p ≤ 0.05, and ### p ≤ 0.001 not-digested coffee versus digested coffee. Differences were considered significant when p-value ≤ 0.05 and highly significant when p-value ≤ 0.0001. * p-value ≤ 0.05, ** p-value ≤ 0.0001 versus LPS-stimulated control; # p-value ≤ 0.05, ### p ≤ 0.001 not-digested coffee versus digested coffee. Mean ± SD of three independent experiments were plotted on the graph. Differences were considered significant when p-value ≤ 0.05, p-value ≤ 0.01 and highly significant when p-value ≤ 0.001. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001 versus untreated control (calculated as fold-change relative to untreated cells, arbitrarily set at 100%) and/or LPS-stimulated cells; # p ≤ 0.05, ## p ≤ 0.01, and ### p ≤ 0.001 not-digested coffee versus digested coffee.

The present study aimed to provide useful information regarding the bioactivities of coffee brew after simulated GiD. Despite the many scientific works present in the literature concerning the beneficial activities of coffee polyphenols in protecting against colon cancer, the study of bioactivities of compounds released after in vitro digestion has been barely investigated to date. Hence, the main goal of this work was to investigate the antioxidant and anti-inflammatory activities of coffee brews after GiD through the HT-29 human colon cancer cell model. The INFOGEST protocol, recognized as one of the most suitable procedures capable of simulating the physiological digestion process, was performed until the duodenal phase, whereas the associated action of Pronase E (mix of bacterial protease) and Viscozyme L (mix of carbohydrases) was used to mimic the gut microbiota activity since the INFOGEST protocol does not cover the large intestinal phase. Although the use of the fecal inoculum is recognized as the most suitable method to simulate in vitro colonic digestion, an ever-expanding amount of scientific works propose as an effective alternative to reproduce the intestinal fermentation the use of a mix of bacterial enzymes, such as Viscozyme L and Pronase E [61] [62] [63] [64] .

Moreover, to better understand the biological activity of coffee, changes in active molecules were also evaluated using a Q-Exactive Orbitrap mass spectrometer. In detail, Mean ± SD of three independent experiments were plotted on the graph. Differences were considered significant when p-value ≤ 0.05, p-value ≤ 0.01 and highly significant when p-value ≤ 0.001. ** p ≤ 0.01, and *** p ≤ 0.001 versus untreated control (calculated as fold-change relative to untreated cells, arbitrarily set at 100%) and/or LPS-stimulated cells; # p ≤ 0.05, not-digested coffee versus digested coffee.

The present study aimed to provide useful information regarding the bioactivities of coffee brew after simulated GiD. Despite the many scientific works present in the literature concerning the beneficial activities of coffee polyphenols in protecting against colon cancer, the study of bioactivities of compounds released after in vitro digestion has been barely investigated to date. Hence, the main goal of this work was to investigate the antioxidant and anti-inflammatory activities of coffee brews after GiD through the HT-29 human colon cancer cell model. The INFOGEST protocol, recognized as one of the most suitable procedures capable of simulating the physiological digestion process, was performed until the duodenal phase, whereas the associated action of Pronase E (mix of bacterial protease) and Viscozyme L (mix of carbohydrases) was used to mimic the gut microbiota activity since the INFOGEST protocol does not cover the large intestinal phase. Although the use of the fecal inoculum is recognized as the most suitable method to simulate in vitro colonic digestion, an ever-expanding amount of scientific works propose as an effective alternative to reproduce the intestinal fermentation the use of a mix of bacterial enzymes, such as Viscozyme L and Pronase E [61] [62] [63] [64] .

Moreover, to better understand the biological activity of coffee, changes in active molecules were also evaluated using a Q-Exactive Orbitrap mass spectrometer. In detail, four phenolic acids, eleven CGAs, and caffeine were identified, quantified, and compared in digested and not-digested coffee brew samples.

Overall, the obtained data highlighted that the filtered coffee brew may represent a rich source of bioactive molecules and the GiD process could affect the monitored active compounds present in a cup of filtered coffee. Moreover, the results clearly indicate that 5-CQA was the predominant active compound found in digested and not-digested coffee samples. Our findings are comparable to those of Farah et al. [65] who reported that 5-CQA accounted for 41 to 48% of total CGAs found in different brewed coffee. Concerning total CGAs occurrence in assayed samples, the levels found in the digested coffee brews were higher than the non-digested ones. These data were in accordance with previously published evidence showing increased CGAs content after the colonic phase. Bekerdam et al. [66] demonstrated that enzymatic hydrolysis using bacterial proteases to mimic the colon stage was able to release CGA and phenolics from coffee samples.

As reported by Pérez-Burillo et al. [67] , melanoidins, which possess significant antioxidant potential, contain in their complex structure a wide range of antioxidant molecules, mainly represented by CGAs and phenolic acids including hydroxycinnamic acids such as ferulic, caffeic, and p-coumaric acids [68] .

Recently, several scientific studies reported that the coffee melanoidins escape the upper digestion process; however, the activity of gut microbiota could play a role in the release of dietary polyphenols, including CGAs, incorporated into melanoidins. In the present work, the amount of hydroxycinnamic acids found in digested samples was higher than in the not-digested ones. This is in agreement with the literature [69] , suggesting that low-molecular catabolites such as the phenolic acids mentioned above represent the main CGA breakdown metabolites mediated by gut microbiota.

CGAs are well recognized as potent molecules with antioxidant and anti-inflammatory activity [70] . Strong scientific evidence has highlighted the ability of CGAs to delay glucose absorption, modulate glucose and lipid metabolism, thus helping to prevent degenerative and non-degenerative diseases [28, [71] [72] [73] .

On the other hand, antioxidant capacity and TPC values of digested and not-digested samples were also assessed and compared. The obtained data showed that both the TPC values and antioxidant capacity of coffee significantly increased after the simulated gastrointestinal process. Regarding the antioxidant activity, the digested samples showed a two-fold increase, in both DPPH and ABTS tests, compared with the not-digested samples, whereas the TPC value of the digested samples increased about 10% after the colonic stage. Similarly, such phenomena were also observed in our previous study [34] , which showed that after the simulated digestion process, the antioxidant capacity and TPC value increased in all types of coffee brews assayed, namely espresso, americano, and instant coffee. Moreover, similar data were obtained by Campos-Vega et al. [74] , who demonstrated that both antioxidant capacity and the colon bioaccessibility of polyphenols from spent coffee, rich in CGAs and melanoidins, were significantly higher after colonic fermentation compared to the non-digested samples. Interestingly, results obtained from FRAP, DPPH, and ABTS assays were positively correlated with TPC values, highlighting that these tests could be suitable to provide reliable information about the antioxidant molecules released after the colonic stage.

The antioxidant capacity of the assayed samples was also estimated by assessing changes in intracellular ROS levels in HT-29 cells. In accordance with literature that support a protective effect of coffee bioactive molecules against oxidative stress, our findings showed that coffee has an important effect in preventing ROS production, which is partly due to its antioxidant activity. It is interesting to note that both digested and not-digested samples induced a significant decrease in the levels of intracellular ROS. In particular, when HT-29 human colon cancer cells were treated for 48h with the assayed samples, the digested coffee highlighted more effective antioxidant activity than the not-digested ones, suggesting that the higher number of phytochemicals found in the samples after the digestion process could play an important role in managing ROS production.

On the other hand, no cytotoxicity effects were revealed in HT-29 cells analysis for both not-digested and digested coffee samples tested at a concentration ranging between 0.250 to 0.750 mg/mL. However, at the highest concentrations tested (1 to 2 mg/mL), not-digested coffee samples showed a drastic reduction in cell viability. Nevertheless, the results showed that the gastrointestinal process was able to release compounds that exhibited a less marked reduction in cell viability than not-digested coffee samples. As a whole, our results are in agreement with several previous studies. In fact, Mojica et al. [11] compared the impact of the different coffee extracts on the growth inhibitory activity of HT-29 cells. The cells were treated with 1 to 50× dilutions of the coffee stock solutions, and the coffee samples were tested without a previous simulated GiD. The authors reported that polyphenolic compounds in different coffee extracts were able to reduce cell growth, revealing that bioactive phytochemicals could positively influence cell survival, avoiding changes in metabolism and mitochondrial structure. Furthermore, Choi et al. [75] reported that among the bioactive compounds present in coffee, including kahweol, caffeic acid, CGA, and caffeine, only kahweol exhibited significant cytotoxicity in HT-29 cell lines, increasing the expression of caspase-3 and inhibiting the HT-29 cell growth. A further in vitro study [76] on the effect of coffee CGA on HT-29 cells reported that treatment with 1 mM CGA significantly reduced the growth rate of the HT-29 cell by 52%.

LPS, an endotoxin of the cell wall of Gram-negative bacteria, is commonly used as an inflammatory stimulus to induce the production of cytokines [52, 57] . Our data showed reduced protein levels of the pro-inflammatory IL-6 and NF-kB in HT-29 cells treated for 48h with coffee extracts and then exposed to LPS. The presence of CGAs in coffee appears to be fundamental. In fact, previous studies [28, 65, 77] have highlighted that coffee CGAs in LPS-stimulated Caco-2 cells were able to downregulate the key transcription factors including the pro-inflammatory cytokines IL-6 and tumor necrosis factor-alpha. In addition, our findings reveled increased levels of IL-10, an anti-inflammatory cytokine, after the treatment with digested coffee than with not-digested coffee extract. LPS treatment also is involved in the intestinal inflammation by inducing intracellular ROS production and oxidative injury in several cell models, including HT-29 cells [52] [53] [54] .

Therefore, we observed that LPS treatment, representing a challenging condition for oxidative stress, induced increased oxidative stress levels in HT-29 cells. Pretreatment with both coffee samples effectively inhibited LPS-induced ROS levels, more efficiently with the digested coffee extract, suggesting that the more effective anti-inflammatory effects observed for this coffee treatment are mediated, at least in part, by antioxidant mechanisms of ROS scavenging.

In conclusion, coffee was demonstrated to exert anti-inflammatory and antioxidant properties. In fact, coffee samples inhibited intracellular ROS and pro-inflammatory pathways, thus exerting potential protective effects against cancer transformation on human colon cells. Therefore, the use of simulated GiD could represent a novel and useful strategy to better evaluate the effects of bioactive compounds present in a food matrix on the gut, chronically exposed to ROS injury and inflammation stimuli, where these compounds can exert their beneficial health effects. However, further in vivo studies are needed to assess the antioxidant and anti-inflammatory potential of coffee extracts and their molecular mechanism.

Supplementary Materials: The following are available online at https://www.mdpi.com/article/10 .3390/nu13124368/s1, Table S1 : Stock solutions composition. Table S2: TPC and antioxidant capacity  evaluated 

Vitro Bioaccessibility and Antioxidant Activity of Coffee Silverskin Polyphenolic Extract and Characterization of Bioactive Compounds Using UHPLC-Q-Orbitrap HRMS. Molecules

Conflicting effects of coffee consumption on cardiovascular diseases: Does coffee consumption aggravate pre-existing risk factors? Processes 2020, 8, 438

Analysis of acrylamide in coffee and dietary exposure to acrylamide from coffee

The impact of coffee on health

Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin

Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study

Coffee, caffeine, and health outcomes: An umbrella review

Coffee consumption and breast cancer risk in the SUN project

Food and COVID-19: Preventive/co-therapeutic strategies explored by current clinical trials and in silico studies

Coffee consumption and the risk of colorectal cancer

The impact of the roast levels of coffee extracts on their potential anticancer activities

Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK

Inhibition of in vivo genotoxicity by coffee

Chlorogenic acid induces reactive oxygen species generation and inhibits the viability of human colon cancer cells. Anti-Cancer Drugs

Long-term consumption of a green/roasted coffee blend positively affects glucose metabolism and insulin resistance in humans

Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice

Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: A cross-sectional study

Metabolic syndrome, hyperinsulinemia, and colon cancer: A review

Coffee consumption and risk of colorectal cancer: A meta-analysis of case-control studies. Cancer Causes Control

Association of coffee consumption with risk of colorectal cancer: A meta-analysis of prospective cohort studies

Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study

High molecular weight coffee melanoidins are inhibitors for matrix metalloproteases

Melanoidins produced by the Maillard reaction: Structure and biological activity

Coffee melanoidins: Structures, mechanisms of formation and potential health impacts

Influence of coffee roasting on the incorporation of phenolic compounds into melanoidins and their relationship with antioxidant activity of the brew

Polyphenolic and hydroxycinnamate contents of whole coffee fruits from China, India, and Mexico

Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions

Chlorogenic acid (CGA): A pharmacological review and call for further research

The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: A comprehensive review of the literature

Microbiota source impact in vitro metabolite colonic production and anti-proliferative effect of spent coffee grounds on human colon cancer cells (HT-29)

Antioxidant effectiveness of coffee extracts and selected constituents in cell-free systems and human colon cell lines

Intake and bioaccessibility of total polyphenols in a whole diet

Colon Bioaccessibility under In Vitro Gastrointestinal Digestion of Different Coffee Brews Chemically Profiled through UHPLC-Q-Orbitrap HRMS

Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy

The small intestine can both absorb and glucuronidate luminal flavonoids

Chlorogenic acid and caffeic acid are absorbed in humans

Coffee, colon function and colorectal cancer

Gut Microbiota Modulation by Dietary Barley Malt Melanoidins

A standardised static in vitro digestion method suitable for food-an international consensus

Colon Bioaccessibility under In Vitro Gastrointestinal Digestion of a Red Cabbage Extract Chemically Profiled through UHPLC-Q-Orbitrap HRMS

Chemical Composition

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay

An Environmentally Friendly Practice Used in Olive Cultivation Capable of Increasing Commercial Interest in Waste Products from Oil Processing

Effects of Trichoderma biostimulation on the phenolic profile of extra-virgin olive oil and olive oil by-products

Analysis of Phenolic Compounds in Commercial Cannabis sativa L. Inflorescences Using UHPLC-Q-Orbitrap HRMS

Chemical Analysis of Minor Bioactive Components and Cannabidiolic Acid in Commercial Hemp Seed Oil

Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia. United Eur

GATA-1 isoforms differently contribute to the production and compartmentation of reactive oxygen species in the myeloid leukemia cell line K562

ZNF224 is a transcriptional repressor of AXL in chronic myeloid leukemia cells

R)-α-lipoic acid protects retinal pigment epithelial cells from oxidative damage

Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-κB pathway quenches intestinal inflammation and oxidative stress injury

Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia

Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression

Pro-inflammatory Th1 and Th17 cells are suppressed during human experimental endotoxemia whereas anti-inflammatory IL-10 producing T-cells are unaffected

Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE2, IL-1β, IL-6 and TNF-α production by AP-1 and NF-κB inactivation in RAW 264.7 macrophages

Anti-inflammatory effects of millet bran derived-bound polyphenols in LPS-induced HT-29 cell via ROS/miR-149/Akt/NF-κB signaling pathway

Quantification of protein concentration by the Bradford method in the presence of pharmaceutical polymers

Annealing of nanostructured silver films produced by supersonic deposition of nanoparticles

Role of ZNF224 in cell growth and chemoresistance of chronic lymphocitic leukemia

Colon bioaccessibility and antioxidant activity of white, green and black tea polyphenols extract after in vitro simulated gastrointestinal digestion

Influence of the addition of chia seeds and germinated seeds and sprouts on the nutritional and beneficial properties of yogurt

Potential bioaccessibility and functionality of polyphenols and cynaropicrin from breads enriched with artichoke stem

Advances in static in vitro digestion models after COST action Infogest consensus protocol

Coffee: Consumption and Health Implications

Incorporation of chlorogenic acids in coffee brew melanoidins

Effect of in vitro digestionfermentation on green and roasted coffee bioactivity: The role of the gut microbiota

Effect of coffee melanoidin on human hepatoma HepG2 cells. Protection against oxidative stress induced by tert-butylhydroperoxide

Catabolism of coffee chlorogenic acids by human colonic microbiota

Chlorogenic acid: A pharmacologically potent molecule

A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk

Coffee, caffeine, and coronary heart disease

Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia

Simulated gastrointestinal digestion and in vitro colonic fermentation of spent coffee (Coffea arabica L.): Bioaccessibility and intestinal permeability

The cytotoxicity of kahweol in HT-29 human colorectal cancer cells is mediated by apoptosis and suppression of heat shock protein 70 expression

Enzymatic synthesis of chlorogenic acid glucoside using dextransucrase and its physical and functional properties

Anti-inflammatory effect of chlorogenic acid on the IL-8 production in Caco-2 cells and the dextran sulphate sodium-induced colitis symptoms in C57BL/6 mice

Funding: This research received no external funding.

The authors declare no conflict of interest.